GFRA1 and breast carcinoma: In breast cancer patients, elevated GFRα1 expression has been linked to tumor lymph-node metastases [27,44,45] and ultimately, the goal of oHSV targeting to GFRα1-expressing cells is therefore to enable safe and effective system-wide treatment.